Literature DB >> 2195097

The growth hormone response to growth hormone releasing hormone in patients previously treated with bilateral adrenalectomy alone for Cushing's disease.

H M Whitehead1, J A McKnight, B Sheridan, A L Kennedy, D R Hadden, A B Atkinson.   

Abstract

Human growth hormone releasing hormone (GHRH) fails to stimulate human growth hormone (GH) in hypercortisolism. In order to study whether the responsiveness to GHRH stimulation returns after cure of the hypercortisolism, the GH response to GHRH was examined in 8 patients at least 5 yr after they had undergone bilateral adrenalectomy as their sole treatment for Cushing's disease. None had current evidence of a pituitary macroadenoma. A group of 8 healthy subjects matched for age and sex formed the control group. All patients and subjects received an iv injection of GHRH 1 microgram/kg, after an overnight fast, blood samples were taken before and at 15, 30, 45, 60, 90 and 120 min. There was no statistical difference between the peak GH or area under curve (AUC) response (median, range) in the two groups studied (adrenalectomized peak GH 9.2 (4.6-32.0) vs 16.5 (7.5-63) mU/l, adrenalectomized AUC response 647.5 (344.2-1489.5) vs 1103.5 (339.7-5188.5) mU/l. Patients with Cushing's disease once cured of hypercortisolism, have a GH response to GHRH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2195097     DOI: 10.1007/BF03349543

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  16 in total

1.  Human pancreatic growth hormone releasing hormone fails to stimulate human growth hormone both in Cushing's disease and in Cushing's syndrome due to adrenocortical adenoma.

Authors:  A E Smals; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Clin Endocrinol (Oxf)       Date:  1986-04       Impact factor: 3.478

2.  Studies of hypothalamic pituitary structure and function in patients previously treated with bilateral adrenalectomy alone for Cushing's disease.

Authors:  R Beacom; A B Atkinson; A L Kennedy; B Sheridan; D R Hadden; J D Merrett; E McIlrath
Journal:  Clin Endocrinol (Oxf)       Date:  1986-08       Impact factor: 3.478

3.  Recovery of hypothalamic-pituitary-adrenal function, growth hormone responsiveness and sleep EEG pattern in a patient following removal of an adrenal cortical adenoma.

Authors:  D T Krieger; G P Gewirtz
Journal:  J Clin Endocrinol Metab       Date:  1974-06       Impact factor: 5.958

4.  Sleep EEG stages and plasma growth hormone concentration in states of endogenous and exogenous hypercortisolemia or ACTH elevation.

Authors:  D T Krieger; S M Glick
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

Review 5.  Physiopathology of Cushing's disease.

Authors:  D T Krieger
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

6.  Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29.

Authors:  V Jordan; C Dieguez; I Lafaffian; M D Rodriguez-Arnao; A Gomez-Pan; R Hall; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1986-03       Impact factor: 3.478

7.  Dichotomic action of glucocorticoids on growth hormone secretion.

Authors:  K Nakagawa; T Ishizuka; T Obara; M Matsubara; K Akikawa
Journal:  Acta Endocrinol (Copenh)       Date:  1987-10

8.  Anterior pituitary hormones in plasma and pituitaries from patients with Cushing's disease.

Authors:  T Suda; H Demura; R Demura; K Jibiki; F Tozawa; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1980-11       Impact factor: 5.958

9.  Bromocriptine reduces growth hormone in acromegaly.

Authors:  P M Bell; A B Atkinson; D R Hadden; L Kennedy; H Leslie; J D Merrett; B Sheridan
Journal:  Arch Intern Med       Date:  1986-06

10.  Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.

Authors:  A Kuwayama; N Kageyama; T Nakane; M Watanabe; N Kanie
Journal:  J Clin Endocrinol Metab       Date:  1981-07       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.